( Epub 2017 Dec 21 PMID: 29274348 ) Varpuluoma O, Jokelainen J, Huilaja L, Tasanen K (2021) GLP-1 analogs and SGLT2 inhibitors do not increase risk of bullous pemphigoid
At TrMD, GLP-1 therapy is approached with a focus on: The goal is not simply weight loss, but optimization of overall health, metabolic function, and longevity through a comprehensive, integrative approach .
[8] The bioavailability of an IV medication is by definition 100%, unlike oral administration where medication may not be fully absorbed, or may be metabolized prior to entering the bloodstream
This can be caused by environmental factors, a demanding lifestyle, or simply the natural process of getting older